PEOPLE - EDAP makes appointment:
This article was originally published in Clinica
Eric Soyer has been appointed as CFO of EDAP (Lyons, France), a manufacturer of minimally-invasive devices for treatment of urological diseases and for high intensity focused ultrasound (HIFU) treatment of prostate cancer. Mr Soyer, who joins EDAP from French nursing home and care clinics firm Medica, where he was CFO, succeeds Thierry Turbant, who will remain with the company as chief financial controller.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.